Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.87
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.93
Today|||52-Week Range
3.55
+35.38%
Year-to-Date
AstraZeneca Gets Positive CHMP Opinion for Asthma Candidate
Nov 13 / Zacks.com - Paid Partner Content
Puma (PBYI) Falls Despite Narrower-Than-Expected Q3 Loss
Nov 10 / Zacks.com - Paid Partner Content